The number refers to California Health and Safety Code § 123707 , which governs the Infant Botulism Treatment and Prevention Unit . This unit is responsible for the manufacture, distribution, and licensure of Botulism Immune Globulin Intravenous (Human) , a life-saving treatment for infants.
Governed by California Health and Safety Code § 123707 , the Infant Botulism Treatment and Prevention Unit isn't just a regulatory body—it’s a manufacturer. It is the primary entity authorized to handle the distribution and licensure of Botulism Immune Globulin Intravenous (Human) , often referred to by its trade name, BabyBIG®. 123707
: To ensure rapid response, the department is exempt from standard competitive bidding for the testing and distribution of the treatment. The number refers to California Health and Safety
The Sentinel of the Cradle: Inside California’s Lifesaving Botulism Unit It is the primary entity authorized to handle
In the quiet labs of the California Department of Public Health, a specialized team works under a unique legal mandate to solve a terrifying medical mystery: infant botulism. While rare, this condition can paralyze an infant’s muscles, making it impossible for them to breathe or eat.
Infant botulism often stems from environmental spores found in soil or honey. For parents, the sudden onset of "floppy baby syndrome" is a nightmare. The unit established by Section 123707 acts as a global safeguard, ensuring that the specialized antibodies needed to neutralize botulinum toxins are always available, tested, and ready for the infants who need them most.